Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment
Clinical trial NCT02873936 · COMPLETED
Trial details
- NCT number
- NCT02873936
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-27
- Primary completion
- 2018-03-20
- Enrollment
- 449
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.